<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522"><gtr:id>4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522</gtr:id><gtr:name>UNLISTED</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F5F667B-3844-49DF-948F-FCA983560AF9"><gtr:id>6F5F667B-3844-49DF-948F-FCA983560AF9</gtr:id><gtr:name>Hannover Medical School</gtr:name><gtr:address><gtr:line1>Carl-Neuberg-Str. 1</gtr:line1><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Biomedical Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522"><gtr:id>4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522</gtr:id><gtr:name>UNLISTED</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F5F667B-3844-49DF-948F-FCA983560AF9"><gtr:id>6F5F667B-3844-49DF-948F-FCA983560AF9</gtr:id><gtr:name>Hannover Medical School</gtr:name><gtr:address><gtr:line1>Carl-Neuberg-Str. 1</gtr:line1><gtr:postCode>D-30625</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5802DD7C-2C14-452F-B2ED-2E799C709ED2"><gtr:id>5802DD7C-2C14-452F-B2ED-2E799C709ED2</gtr:id><gtr:firstName>Juergen</gtr:firstName><gtr:surname>Haas</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501453"><gtr:id>637837AF-82CC-4695-871C-FCAEA6FA7B2B</gtr:id><gtr:title>Phenotypical and functional modulation of B-lymphocytes by KSHV infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501453</gtr:grantReference><gtr:abstractText>Herpesviruses are widely spread throughout the general population. In most cases, they only cause harmless childhood infections. In contrast to other pathogens, however, they are not eliminated from the body but rather stay in specific tissues for the rest of the life of the host. Under certain conditions, for example in immunocompromised patients, they are able to reactivate and cause life-threatening diseases. To achieve the life-long persistence in the host, herpesviruses developed a variety of measures to cope with its immune system. In contrast to other viruses, they express a large number (between approximately 70 and 170) of different proteins, most of which have not been characterized yet in terms of their function. A very large percentage of herpesviral proteins are involved in manipulating the host and its immune system. In this project, we will focus on a herpesvirus called ?Kaposi Sarcoma associated Herpesvirus? (KSHV) which causes skin tumors and lymphomas, predominantly in immuncompromised individuals as for example in AIDS patients. This herpesvirus infects cells which are very important for the immune system since they are able to produce antibodies, so-called B-lymphocytes. The infection with KSHV alters B-lymphocytes severely and has the effect that proteins which normally can be found on the surface disappear. Due to this elimination of surface proteins the infected cells can not be recognized and killed by the immune system any more. We will try to elucidate the mechanisms leading to an alteration of KSHV-infected cells and the disappearance of B-lymphocyte surface proteins. Particularly, we will search for those viral proteins which are responsible for the manipulation of B-lymphocytes. If we understand how KSHV alters infected cells, we will be able to develop new drugs which disrupt these mechanisms so that the virus can not hide from the immune system any more and is eliminated from the body. Moreover, by understanding these mechanisms we will be able to use them as tools in diseases in which a suppression of the immune system is intended, for example in auto-immune diseases, and apply them in future approaches in vaccination and gene therapy.</gtr:abstractText><gtr:technicalSummary>Kaposi Sarcoma associated Herpesvirus (KSHV) is a human gammaherpesvirus causing Kaposi sarcomas and B-cell lymphomas, particularly in immunocompromised individuals as for example AIDS patients. It predominantly infects endothelial cells and B-lymphocytes, which constitute the viral reservoir during latency. We were recently able to show that persistent infection of B-cells with KSHV induces a complete downmodulation of B-cell and accessory molecules (null phenotype) and the secretion of a variety of cellular soluble factors. The majority of KSHV-infected B-cells is latently infected and expresses only a few viral transcripts, including a transcript encoded by the kaposin locus. This mRNA encodes five protein isoforms, as well as 11 miRNAs which recently have been detected. In our previous experiments, we investigated the expression pattern of the kaposin protein isoforms, and identified the kaposin A isoform as one of the transforming KSHV proteins. Moreover, we could show that the dramatic phenotypical changes result in an almost complete resistance against the innate and adaptive immune system. In the proposed study, we will investigate the viral mechanisms leading to phenotypical and functional changes of B-cells and their resistance against the immune system, particularly the potential role of virally encoded miRNAs and auto/paracrine mechanisms.</gtr:technicalSummary><gtr:fund><gtr:end>2010-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>619954</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hannover Medical School</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute for Virology</gtr:department><gtr:description>KSHV miRNA targets involved in DNA damage repair</gtr:description><gtr:id>13F7C0C7-E005-4E13-AB43-DAE4C3746E31</gtr:id><gtr:impact>knowledge</gtr:impact><gtr:outcomeId>atq9RNMtCkf-1</gtr:outcomeId><gtr:partnerContribution>experimental validation of miRNA targets involved in DNA damage repair</gtr:partnerContribution><gtr:piContribution>we provided possible target genes of KSHV miRNA targets</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southern California</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Norris Comprehensive Cancer Center USC</gtr:department><gtr:description>KSHV kaposin is involved in lymphatic reprogramming</gtr:description><gtr:id>1529A88D-D504-413E-B2C2-AD4D9621EC1E</gtr:id><gtr:impact>publication</gtr:impact><gtr:outcomeId>NBzwNcppj34-1</gtr:outcomeId><gtr:partnerContribution>knowledge about the function of kaposin</gtr:partnerContribution><gtr:piContribution>provision of reagents and protocols</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Edinburgh Infectious Diseases</gtr:department><gtr:description>Identification of protein interactors of Listeria internalins</gtr:description><gtr:id>FF127925-050E-487C-B2FB-6CB792513470</gtr:id><gtr:impact>continuing collaboration, publication pending</gtr:impact><gtr:outcomeId>DF05B948AD6-1</gtr:outcomeId><gtr:partnerContribution>Development of new concepts</gtr:partnerContribution><gtr:piContribution>Collaboration on pathogen-host interactions in Listeria and Rhodococcus</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Roslin Institute</gtr:department><gtr:description>Host factors influencing vaccinia infection</gtr:description><gtr:id>E3667128-D616-40AB-95AF-EF2BF2EE84B7</gtr:id><gtr:impact>dataset of host factors relevant for MVA infection</gtr:impact><gtr:outcomeId>tp2qP3obpH8-1</gtr:outcomeId><gtr:partnerContribution>recombinant MVA vaccina vector</gtr:partnerContribution><gtr:piContribution>RNAi screening facility</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>programme grant/BMBF</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>German Federal Ministry of Education and Research</gtr:fundingOrg><gtr:id>6E3DD111-35EF-4EEC-B6EF-FE5D02C6482C</gtr:id><gtr:outcomeId>CEB4C11E9620</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>188123</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>project grant</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>9F2AA31A-33E9-42FD-A4FC-8B3B29392456</gtr:id><gtr:outcomeId>C09105F1C560</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>KSHV Lana activates the SRE signalling pathway by binding to SRF and Mediator subunits Med25, Med15 and Med23</gtr:description><gtr:id>81DEC232-F11B-4C87-9675-6E28D6D3BB41</gtr:id><gtr:impact>possible drug target to inhibit KSHV oncogenesis</gtr:impact><gtr:outcomeId>bKPe152m6wy</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>KSHV Lana activates SRE</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>114 cellular targets of KSHV miRNAs were identified by RISC immunoprecipitation</gtr:description><gtr:id>8C0DD489-0231-4627-810B-6D1D7C216EEF</gtr:id><gtr:impact>possible inhibition of KSHV induced tumors</gtr:impact><gtr:outcomeId>W1A69izxPsQ</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Identification of KSHV miRNA targets</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>371711D3-2F31-4AF8-9C9B-41700B12773C</gtr:id><gtr:title>LuMPIS--a modified luminescence-based mammalian interactome mapping pull-down assay for the investigation of protein-protein interactions encoded by GC-low ORFs.</gtr:title><gtr:parentPublicationTitle>Proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a13eb7d2c8db24461179901e6acc5fce"><gtr:id>a13eb7d2c8db24461179901e6acc5fce</gtr:id><gtr:otherNames>Vizoso Pinto MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1615-9853</gtr:issn><gtr:outcomeId>A27FBF33587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B10C152E-B7B4-4415-8D9D-01473456D73E</gtr:id><gtr:title>The heterogeneous nuclear ribonucleoprotein K is important for Herpes simplex virus-1 propagation.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/608f4523fc2208c0812761712cfa69c1"><gtr:id>608f4523fc2208c0812761712cfa69c1</gtr:id><gtr:otherNames>Schmidt T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>FkbUNs5QmsT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2DAA698-8442-483A-A30F-D750077634F2</gtr:id><gtr:title>Functional characterization of the essential tail anchor of the herpes simplex virus type 1 nuclear egress protein pUL34.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41c011cd44e5645487424083afb074bb"><gtr:id>41c011cd44e5645487424083afb074bb</gtr:id><gtr:otherNames>Ott M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>ngM87pVMFm3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4275DF3C-BFFD-4162-8655-3FCB95798AC6</gtr:id><gtr:title>Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d1f0f0df0a5f6c0644cb3bec7a5e03"><gtr:id>26d1f0f0df0a5f6c0644cb3bec7a5e03</gtr:id><gtr:otherNames>Verweij MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56dff6dfdaf252.91816017</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DC77BFE-D71A-4BD9-914C-D2543FA2BC3E</gtr:id><gtr:title>pEPito: a significantly improved non-viral episomal expression vector for mammalian cells.</gtr:title><gtr:parentPublicationTitle>BMC biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f45c76565cae4663310317b0b3d8973"><gtr:id>4f45c76565cae4663310317b0b3d8973</gtr:id><gtr:otherNames>Haase R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1472-6750</gtr:issn><gtr:outcomeId>MHjCi9SMt8d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>046AD633-E96D-4425-B8EA-2B5FE5571E83</gtr:id><gtr:title>Genomic and surface proteomic analysis of the canine pathogen Staphylococcus pseudintermedius reveals proteins that mediate adherence to the extracellular matrix.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2424fa5f0a4904c657620c014cb54f6"><gtr:id>d2424fa5f0a4904c657620c014cb54f6</gtr:id><gtr:otherNames>Bannoehr J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>R53ojGgeJBJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D3AE8DE-F6F9-43A6-BA1A-18297C0F0F90</gtr:id><gtr:title>siRNA Screening for Genes Involved in HSV-1 Replication.</gtr:title><gtr:parentPublicationTitle>Bio-protocol</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e8e620d7475dd142e4954247b874be1"><gtr:id>0e8e620d7475dd142e4954247b874be1</gtr:id><gtr:otherNames>Griffiths SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2331-8325</gtr:issn><gtr:outcomeId>5a325bad697515.77721691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95E00221-46A9-4C9E-AD87-44B199865DD5</gtr:id><gtr:title>Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24490f379a8657893616a16c49f55475"><gtr:id>24490f379a8657893616a16c49f55475</gtr:id><gtr:otherNames>Heinzelmann K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>EED60AC0_BEED60AC0_B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63164BD0-2C1A-46E1-B5AE-E531E383EA8B</gtr:id><gtr:title>A systematic analysis of host factors reveals a Med23-interferon-? regulatory axis against herpes simplex virus type 1 replication.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e8e620d7475dd142e4954247b874be1"><gtr:id>0e8e620d7475dd142e4954247b874be1</gtr:id><gtr:otherNames>Griffiths SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_16269_29_23950709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68640B10-5CD0-4018-9479-75C9E4EFBE3D</gtr:id><gtr:title>Screening colonies of pooled ORFeomes (SCOOP): a rapid and efficient strategy for expression screening ORFeomes in Escherichia coli.</gtr:title><gtr:parentPublicationTitle>Protein expression and purification</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a381a98fdedf5fd234b225a476057ae"><gtr:id>9a381a98fdedf5fd234b225a476057ae</gtr:id><gtr:otherNames>Dahlroth SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1046-5928</gtr:issn><gtr:outcomeId>7BD2D4E5DB6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5804CE71-078D-41E4-B08A-8E78B2F2438A</gtr:id><gtr:title>Virus-host interactomes and global models of virus-infected cells.</gtr:title><gtr:parentPublicationTitle>Trends in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/815f291aa6da6728a1e36804a870619a"><gtr:id>815f291aa6da6728a1e36804a870619a</gtr:id><gtr:otherNames>Friedel CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0966-842X</gtr:issn><gtr:outcomeId>enXX8K9fnYG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>286FB4DF-0CCC-43D7-98C6-CBA0FED0F9AA</gtr:id><gtr:title>Expression, purification, crystallization and preliminary X-ray analysis of ORF60, the small subunit (R2) of ribonucleotide reductase from Kaposi's sarcoma-associated herpesvirus (KSHV).</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0470b684b3354292bd5fe7dd40bf8089"><gtr:id>0470b684b3354292bd5fe7dd40bf8089</gtr:id><gtr:otherNames>Gurmu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>aibCupPFszU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>481A8E26-B3FA-4BC6-A8AB-F06607FEDEB2</gtr:id><gtr:title>Murine gammaherpesvirus 68 contains two functional lytic origins of replication.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7512015ec72999f2302ef6ccc9f27523"><gtr:id>7512015ec72999f2302ef6ccc9f27523</gtr:id><gtr:otherNames>Adler H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>AEF17F272B8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDC52DD5-CCF7-444B-874B-3DB31F07003B</gtr:id><gtr:title>A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens.</gtr:title><gtr:parentPublicationTitle>Virology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a13eb7d2c8db24461179901e6acc5fce"><gtr:id>a13eb7d2c8db24461179901e6acc5fce</gtr:id><gtr:otherNames>Vizoso Pinto MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1743-422X</gtr:issn><gtr:outcomeId>q6rEBXebH7a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DF47CED-0E73-4937-AC9F-A0CD9C25B61F</gtr:id><gtr:title>Viruses and microRNAs: a toolbox for systematic analysis.</gtr:title><gtr:parentPublicationTitle>Wiley interdisciplinary reviews. RNA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01491919fd15d19b11422d7023d70135"><gtr:id>01491919fd15d19b11422d7023d70135</gtr:id><gtr:otherNames>Lieber D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-7004</gtr:issn><gtr:outcomeId>pm_16269_29_21976283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AD28111-2D2E-45AA-AF95-8B35756D222D</gtr:id><gtr:title>Small noncoding RNA: novel targets for antiviral therapy.</gtr:title><gtr:parentPublicationTitle>Future microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba9690800b087a0036086166e9af9eb1"><gtr:id>ba9690800b087a0036086166e9af9eb1</gtr:id><gtr:otherNames>D?lken L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1746-0913</gtr:issn><gtr:outcomeId>09A7509B691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA828F4C-6093-42AA-8EC4-C78789CD0A83</gtr:id><gtr:title>The M10 locus of murine gammaherpesvirus 68 contributes to both the lytic and the latent phases of infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e710d91e19b5d787d4ca3141100b773c"><gtr:id>e710d91e19b5d787d4ca3141100b773c</gtr:id><gtr:otherNames>Flach B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>D81094A15B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB4E18FF-20CC-4A3D-AAE3-782D71ABD532</gtr:id><gtr:title>Epstein-barr virus encodes three bona fide ubiquitin-specific proteases.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41588143c816a6d5cdec63d3960fe142"><gtr:id>41588143c816a6d5cdec63d3960fe142</gtr:id><gtr:otherNames>Sompallae R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>4475DB459C9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62B827E6-3C6B-4AFC-884B-BEEA1AB8B174</gtr:id><gtr:title>Screening for host proteins with pro- and antiviral activity using high-throughput RNAi.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e8e620d7475dd142e4954247b874be1"><gtr:id>0e8e620d7475dd142e4954247b874be1</gtr:id><gtr:otherNames>Griffiths SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>585d5a7e8c52d8.56313823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6DDC606-BC0B-4A25-AE91-969EF08050B5</gtr:id><gtr:title>Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba9690800b087a0036086166e9af9eb1"><gtr:id>ba9690800b087a0036086166e9af9eb1</gtr:id><gtr:otherNames>D?lken L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>G9KbbMkKwWH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3333534B-2A90-48F2-B1E0-5008C4129BB4</gtr:id><gtr:title>Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57bd7dfe4fbbce3120e1e29e47d981ff"><gtr:id>57bd7dfe4fbbce3120e1e29e47d981ff</gtr:id><gtr:otherNames>Jing L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56dff6df864b44.32849971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07C3D0ED-AA01-4413-A0E2-3CA5FEB0B403</gtr:id><gtr:title>Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d72aaee179276627a36e39ca23c331b5"><gtr:id>d72aaee179276627a36e39ca23c331b5</gtr:id><gtr:otherNames>Lee HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>e1RArqim43L</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB6BD78C-CE86-40D8-8833-A58E1C9D0431</gtr:id><gtr:title>Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5109f7d7c6525fd7f49d58ccc9942bef"><gtr:id>5109f7d7c6525fd7f49d58ccc9942bef</gtr:id><gtr:otherNames>von Brunn A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>94C4F961593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>329843C3-47AC-4ED9-8C80-ADE68D595E29</gtr:id><gtr:title>The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70c11e2cd9720ccd2e49cbe372be61a6"><gtr:id>70c11e2cd9720ccd2e49cbe372be61a6</gtr:id><gtr:otherNames>Pfefferle S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>SUJTpgAMm7j</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7E458D1-3ED6-497A-92AE-BB5AF36E3513</gtr:id><gtr:title>Systematic analysis of the IgG antibody immune response against varicella zoster virus (VZV) using a self-assembled protein microarray.</gtr:title><gtr:parentPublicationTitle>Molecular bioSystems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bba2b0416ffd06453917977b02f427a6"><gtr:id>bba2b0416ffd06453917977b02f427a6</gtr:id><gtr:otherNames>Ceroni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-2051</gtr:issn><gtr:outcomeId>EXF8nT9mzXv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CE2EA53-7910-4864-8F57-9F75B59EE36A</gtr:id><gtr:title>Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fdc90133a49453d074f6ef2c37f4c88"><gtr:id>7fdc90133a49453d074f6ef2c37f4c88</gtr:id><gtr:otherNames>Sarek G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>C4B75715C97</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96BAEA40-EC65-4151-A6D1-9970D7D1B3A3</gtr:id><gtr:title>Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/120caae41fc653746c9cef8d008c4769"><gtr:id>120caae41fc653746c9cef8d008c4769</gtr:id><gtr:otherNames>Scholz BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_16269_29_23696732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C1B50C5-CEBB-4B86-9A40-BB76A0E21467</gtr:id><gtr:title>Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fdc90133a49453d074f6ef2c37f4c88"><gtr:id>7fdc90133a49453d074f6ef2c37f4c88</gtr:id><gtr:otherNames>Sarek G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>pm_16269_29_22469985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FCB6C93-2BD8-4572-B647-C83D1EE8F6B1</gtr:id><gtr:title>Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/930bdb6adf32b3eabba707606c91add1"><gtr:id>930bdb6adf32b3eabba707606c91add1</gtr:id><gtr:otherNames>Laing KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>56dff6e0555338.71792470</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9024CBC9-C1C0-4445-B65F-E85ACBEF41E4</gtr:id><gtr:title>The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67feedbc2818261e28adf88066978a6d"><gtr:id>67feedbc2818261e28adf88066978a6d</gtr:id><gtr:otherNames>Raziorrouh B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>KfRVWsXtFKS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72EAC5BF-F636-4FE5-84F0-CDC58927C0D2</gtr:id><gtr:title>Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57bd7dfe4fbbce3120e1e29e47d981ff"><gtr:id>57bd7dfe4fbbce3120e1e29e47d981ff</gtr:id><gtr:otherNames>Jing L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>pm_16269_29_22214845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ADD9696-E68A-4E72-B8B3-AA04292B317A</gtr:id><gtr:title>Crystal structure of the shutoff and exonuclease protein from the oncogenic Kaposi's sarcoma-associated herpesvirus.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a381a98fdedf5fd234b225a476057ae"><gtr:id>9a381a98fdedf5fd234b225a476057ae</gtr:id><gtr:otherNames>Dahlroth SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>qyMD3feHyCw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>337CEB8B-5E03-4277-B694-4A3B6160BA20</gtr:id><gtr:title>Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0829a8af273aa99c5c013cfa29a63c74"><gtr:id>0829a8af273aa99c5c013cfa29a63c74</gtr:id><gtr:otherNames>Suffert G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_16269_29_22174674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CD4750E-5A6E-4304-8CD2-5FBAAA5B4E8B</gtr:id><gtr:title>Connecting viral with cellular interactomes.</gtr:title><gtr:parentPublicationTitle>Current opinion in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb53746770ab5ecff202f4efbcef2626"><gtr:id>bb53746770ab5ecff202f4efbcef2626</gtr:id><gtr:otherNames>Bailer SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1369-5274</gtr:issn><gtr:outcomeId>49AC7C8AF3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABD7C69A-FFB6-45F9-AEC1-5857A89C53D6</gtr:id><gtr:title>Herpesviral protein networks and their interaction with the human proteome.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24a4d98e272e4f1f3bfb9e601590a79d"><gtr:id>24a4d98e272e4f1f3bfb9e601590a79d</gtr:id><gtr:otherNames>Uetz P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>D925F20C9CD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>648AF959-8723-41CE-A608-0A862FBE95D8</gtr:id><gtr:title>Evolutionarily conserved herpesviral protein interaction networks.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c3526069eb4a108ab7ec79ff37848fd"><gtr:id>3c3526069eb4a108ab7ec79ff37848fd</gtr:id><gtr:otherNames>Fossum E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>07856D27E7E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B56C048C-F64E-4259-BAE1-6BE7E44C10F3</gtr:id><gtr:title>The miRNA-targetome of KSHV and EBV in human B-cells.</gtr:title><gtr:parentPublicationTitle>RNA biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c22725cf0e598db5f60f8edd939c506c"><gtr:id>c22725cf0e598db5f60f8edd939c506c</gtr:id><gtr:otherNames>Malterer G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1547-6286</gtr:issn><gtr:outcomeId>XFc7HeEwh5y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E4A78EF-E0DB-431A-9988-5D3D0E7405A2</gtr:id><gtr:title>Varicella zoster virus ORF25 gene product: an essential hub protein linking encapsidation proteins and the nuclear egress complex.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a13eb7d2c8db24461179901e6acc5fce"><gtr:id>a13eb7d2c8db24461179901e6acc5fce</gtr:id><gtr:otherNames>Vizoso Pinto MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>B8n88H4SNRL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1280A9AE-F02F-4A24-831B-11A97CE8F133</gtr:id><gtr:title>YIP1 family member 4 (YIPF4) is a novel cellular binding partner of the papillomavirus E5 proteins.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/801e60f22e59f3743776586107b7098b"><gtr:id>801e60f22e59f3743776586107b7098b</gtr:id><gtr:otherNames>M?ller M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56dff6e02ae586.93437986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A461420D-D6F0-417A-B233-8A5C8AC7FAE3</gtr:id><gtr:title>The Role of Interferon-? Locus Polymorphisms in Hepatitis C and Other Infectious Diseases.</gtr:title><gtr:parentPublicationTitle>Journal of innate immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e8e620d7475dd142e4954247b874be1"><gtr:id>0e8e620d7475dd142e4954247b874be1</gtr:id><gtr:otherNames>Griffiths SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1662-811X</gtr:issn><gtr:outcomeId>56dff6e00df3f9.50456665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4040DF2D-B2AD-4542-918E-244BEB8C14F9</gtr:id><gtr:title>VZV Replication Assays.</gtr:title><gtr:parentPublicationTitle>Bio-protocol</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e8e620d7475dd142e4954247b874be1"><gtr:id>0e8e620d7475dd142e4954247b874be1</gtr:id><gtr:otherNames>Griffiths SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2331-8325</gtr:issn><gtr:outcomeId>5a3258d0906728.60572160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1B2B2CF-AF76-474C-9F59-B44B7DA794E6</gtr:id><gtr:title>Epstein-Barr virus LF2: an antagonist to type I interferon.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/688c724f0634d353269671f0a3751196"><gtr:id>688c724f0634d353269671f0a3751196</gtr:id><gtr:otherNames>Wu L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>167B2B0F260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07122C11-296C-49ED-8855-B627FE3058F9</gtr:id><gtr:title>Kaposi's sarcoma-associated herpesvirus Lana-1 is a major activator of the serum response element and mitogen-activated protein kinase pathways via interactions with the Mediator complex.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f44a04eb85552be5fc31a4902a0068fb"><gtr:id>f44a04eb85552be5fc31a4902a0068fb</gtr:id><gtr:otherNames>Roupelieva M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>dedk3oMqY1z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>404D8835-7408-45D4-A667-71525DEE0ABB</gtr:id><gtr:title>Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c29d6e2adeabc8c709f612faa5f51d7"><gtr:id>0c29d6e2adeabc8c709f612faa5f51d7</gtr:id><gtr:otherNames>Yoo J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>YYUA5caAMSa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EDD5F64-4F4B-4890-A695-0D08DA33E200</gtr:id><gtr:title>Improving the yeast two-hybrid system with permutated fusions proteins: the Varicella Zoster Virus interactome.</gtr:title><gtr:parentPublicationTitle>Proteome science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/502442220ddcaaf71cbb702f807aae77"><gtr:id>502442220ddcaaf71cbb702f807aae77</gtr:id><gtr:otherNames>Stellberger T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1477-5956</gtr:issn><gtr:outcomeId>iAeYZ6Q6teE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFC31FDD-171E-4EE4-BE5A-8CD0286C26E4</gtr:id><gtr:title>Protein subassemblies of the Helicobacter pylori Cag type IV secretion system revealed by localization and interaction studies.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78dda6fc835de07abfbeb0a45b9c2406"><gtr:id>78dda6fc835de07abfbeb0a45b9c2406</gtr:id><gtr:otherNames>Kutter S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>5A0AA69C9E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E5AD71B-0D1B-49D4-9188-D509C49841D8</gtr:id><gtr:title>HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b6d1b84696df7259b815e773b8f7237"><gtr:id>3b6d1b84696df7259b815e773b8f7237</gtr:id><gtr:otherNames>Stanton RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>54623fc392fb56.44127507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40A201F7-745E-477B-878D-300B6CCA2E13</gtr:id><gtr:title>Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e56cebb303bf330def190aaeca600b1"><gtr:id>8e56cebb303bf330def190aaeca600b1</gtr:id><gtr:otherNames>Kurktschiev PD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>54623fc33690e0.93860380</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501453</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>